The company is located in Waltham, MA.
Deloitte & Touche LLP acts as the company’s independent auditor.
The company began publicly trading on September 20, 2021.
The company’s fiscal year starts on January 1st, 2021 and ends December 31st, 2021.
Vicarious Surgical shares are traded on the NYSE under the ticker symbol “RBOT”.
Vicarious Surgical does not expect to declare or pay any cash or other dividends on its common stock.
Vicarious Surgical’s transfer agent is Continental Stock Transfer & Trust Company.
If your shares are held in street name (by your broker), you must notify the securities firm holding your stock. If you hold stock certificates in your name, address changes should be submitted in writing by U.S. Mail to our transfer agent at the address below or by visiting https://continentalstock.com/contact/.
1 State Street, 30th Floor New York, NY 10004
Vicarious Surgical does not currently have a direct stock purchase plan.
Shares of Vicarious Surgical can be purchased through the broker of your choice.
We will announce our earnings releases. Releases can be found under the News section of our investors page.
For investor inquiries, please contact Kaitlyn Brosco at Kbrosco@vicarioussurgical.com or Marissa Bych, Gilmartin Group at IR@vicarioussurgical.com.
The company is incorporated in the state of Delaware.
For access to the company’s SEC filings, including quarterly and annual reports, please visit the SEC’s Electronic Data Gathering, Analysis, and Retrieval (EDGAR) system, or visit the Financials section of our investors page.
The company’s CUSIP numbers are as follows: RBOT: 92561V109; RBOTW: 92561V117
For inclusion on the company’s distribution list, please make a request to IR@vicarioussurgical.com.
Vicarious Surgical will announce when hosting annual meetings and notify shareholders via proxy. The announcements can be found under the News section of our investors page.